Radiation-triggered acute exacerbation of progressive fibrotic interstitial lung diseases: ‘Are we advancing the frontier or crossing a dangerous line?’
Therapeutic Advances in Respiratory Disease
Published online on May 06, 2026
Abstract
Therapeutic Advances in Respiratory Disease, Volume 20, January-December 2026.
Fibrotic interstitial lung diseases (F-ILDs) are increasingly complicated by early-stage non-small cell lung cancer. For many of these patients, stereotactic ablative body radiotherapy (SABR) is the only feasible curative-intent option. However, pre-...
Fibrotic interstitial lung diseases (F-ILDs) are increasingly complicated by early-stage non-small cell lung cancer. For many of these patients, stereotactic ablative body radiotherapy (SABR) is the only feasible curative-intent option. However, pre-...